PROXY STATEMENT

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

August 3, 1999

Period of Report

March 31, 1999

Accession Number

0001053369-99-000016

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →